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Anti-inﬂammatory cytokinesIn our previous studies, we discussed the protective efﬁcacy of the two types of vaccine formulation
namely SOMVs (single-serotype outer membrane vesicles) and MOMVs (multi-serotype outer membrane
vesicles). Here, we compared the immunogenic roles of these two types of formulations and also studied
general immunomodulation by Shigella OMVs in adult BALB/c mice. The production of various
pro-inﬂammatory (TNF-a, IL-1b, IL-6, IL-12, IL-18, IFN-c) and anti-inﬂammatory (IL-4 and IL-10) cytokine
proﬁle were assessed by in vivo, ex vivo and in vitro studies. MOMVs treated mice showed signiﬁcantly
enhanced cytokine production compared to SOMVs treated mice. MOMVs treatment has also upregulated
iNOS mRNA synthesis in macrophages. Overall the OMVs of Shigellawere found to show a mixed Th1/Th2
response and maintain the balance between pro-inﬂammation and anti-inﬂammation in mice. This will
be crucial in the development of the next generation OMVs based vaccine against shigellosis.
 2015 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Vesicles are likely a key factor in effecting an inﬂammatory
response to host. Outer membrane vesicles or OMVs produced by
colonizing bacteria encounter and may be taken up by epithelial
cells and macrophages to trigger an immediate innate host
response. The ability of outer membrane vesicles to trigger
inﬂammatory responses was thoroughly investigated by Alaniz
et al. [1]. Their analysis demonstrated that OMVs from Salmonella
enterica serovar Typhimurium are potent stimulators of
pro-inﬂammatory cytokine secretion and immune cell activation.
A pro-inﬂammatory response to OMVs was also observed for
several other pathogens like Pseudomonas aeruginosa [2], Shigella
ﬂexneri [3], Vibrio cholerae [4], Neisseria meningitidis [5,6],
Helicobacter pylori [7]. Likewise, OMVs puriﬁed from the ﬁsh patho-
gen Vibrio anguillarum stimulated the production of the
pro-inﬂammatory cytokines TNF-a, IL-1b, and IL-6 when inoculated
into ﬂounder [8].
The induction of pro-inﬂammatory and anti-inﬂammatory
cytokines are important in determining whether the immune sys-
tem is successful in providing protection against speciﬁc patho-
genic organisms [9,10] like Shigella which causes shigellosis, a
signiﬁcant public health burden predominantly in children under
the age of 5 years, in developed and developing countries, leadingto possibly 1.1 million deaths annually worldwide [11]. In order to
develop a novel OMVs based vaccine against shigellosis, the
balance between pro-inﬂammatory and anti-inﬂammatory cyto-
kines is therefore needs to be understood. Here, we have studied
the immunomodulatory role of Shigella OMVs, analyzing the
pro-inﬂammatory and anti-inﬂammatory cytokine level in mouse
model and also compared between our newly developed OMVs based
vaccine formulations: SOMVs (single-serotype outer membrane
vesicles) and MOMVs (multi-serotype outer membrane vesicles).
2. Methodology
2.1. Animals
BALB/c mice, six to seven weeks old, were taken from animal
resource department of National Institute of Cholera and Enteric
Diseases (NICED) and were caged in a group of ﬁve at 25 C with
75% humidity. They were fed sterile food and water under the care
of full time staff and in accordance with the rules of the institu-
tional animal ethics committee (Apro/77/24/11/2010, Reg. No.
NICED/ CPCSEA (AW) 215/2009–2015).
2.2. Analysis of pro-inﬂammatory and anti-inﬂammatory cytokines in
mouse serum
Mice were immunized following the same strategy as explained
in our previous publication [12]. Blood was collected on six
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[12]. TNFa, IL-1b, IFN-c, IL-6, IL-10 and IL-4 were measured in both
immunized and non-immunized mouse serum with speciﬁc ELISA
kits (Invitrogen, USA) following the instruction manual; Brieﬂy,
50 ll of standards or test samples were added to the appropriate
microtiter plate wells (supplied with the kit) followed by the
addition of 50 ll biotin conjugate and incubated for 90 min at
room temperature. The wells were washed and 100 ll of
Streptavidin conjugated to Horseradish Peroxidase (HRP) was
added to each microplate well and incubated again for 30 min at
room temperature. After washing, 3,30,5,50 tetramethyl-benzidine
(TMB) substrate solution was added to each well and incubated
for another 30 min at room temperature. The enzyme-substrate
reaction was terminated by the addition of 100 ll sulphuric acid
solution and the colour change was measured spectrophotometri-
cally at a wavelength of 450 nm ± 2 nm. The concentration of the
cytokines in the samples was determined by comparing the optical
density of the samples to the respective standard curves.
2.3. Analysis of pro-inﬂammatory and anti-inﬂammatory cytokines in
mouse peritoneal macrophage cells
Peritoneal macrophages from BALB/c mice were isolated and
cultured following the protocol explained previously [13]. Brieﬂy,
cells were seeded per well at a concentration of 1  106 cells/ml
in 12 well tissue culture plates (Nunc) and were cultured at
37 C in a humidiﬁed 5% CO2 atmosphere. The integrity of the
monolayer was monitored by inverted Phase contrast microscopy.
The day before the experiment, cells were grown in serum free
RPMI. Next day, cells were washed three times and the medium
was replaced with antibiotic-free, serum-free RPMI, just before
adding the OMVs. One control experiment, without any antigen,
was set along with the test. Cells were incubated with OMVs for
overnight. IL-12, IL-18, IL-6 and IL-10 secretion in the supernatant
was measured following the instruction manual of respective
ELISA Kits (Invitrogen, USA). A curve of absorbance versus concen-
tration of each cytokine studied here, were plotted. The concentra-
tions of different cytokines in the samples were determined by
comparing the optical density of the samples to the standard curve.
2.4. Quantiﬁcation of iNOS mRNA by real time PCR
The inducible nitric oxide synthase (iNOS) mRNA in SOMVs,
MOMVs and untreated macrophages was quantiﬁed. iNOS is
involved in immune response, produces nitric oxide (NO), as an
immune defence mechanism. At ﬁrst the total mRNA was collected
from the macrophages using the mRNA isolation kit from
Invitrogen. cDNA was synthesised from these mRNA using
Superscript II Reverse Trancriptase kit (Invitrogen) and quantiﬁed
by Real-time PCR using Syber Greenmaster mix. Fold changes were
calculated by 2DDCt method.
2.5. Peritoneal macrophage and CD4+ T cells co-culture
CD4+ T cells were isolated from spleens of BALB/c mice. Spleens
were strained over 70 lm nylon cell strainers. The resulting single
cell suspension of splenocytes containing CD4+ T cells was then
processed following the instruction manual of the CD4+ T cell iso-
lation kit by Invitrogen. The purity of the cell preparations was
determined by FACS analysis with phycoerythrin-conjugated
anti-CD4+ antibody (BD PharMingen). Routinely, the purity of the
cell preparations was >95%. The cells were then washed in RPMI
1640 containing 2% FCS, 5 U/ml penicillin G, 5 lg/ml streptomycin,
and 0.1% gentamycin. Prior to the experimentation the media was
replaced with serum free RPMI 1640.CD4+ T cells (2  105) were cultured with 105 peritoneal macro-
phages in a ﬁnal volume of 200 ll in round-bottomed 12-well
plates in the presence or absence of antigen for 4 days in serum
free RPMI 1640. Prior to the co-culture, the macrophages were
stimulated in vitro with the OMVs for 6 h. After 4 days, IFN-c
and IL-4 secretion in the supernatant were measured following
the instruction manual of respective ELISA Kits (Invitrogen, USA).
The concentrations of different cytokines in the samples were
determined by comparing the optical density of the samples to
the respective standard curve.2.6. Statistical analysis
Data were expressed as the mean ± standard deviation (SD).
Each experiment was repeated at least three times. Statistical sig-
niﬁcance was measured by analysis of variance (ANOVA) and
two-tailed type 3 Student’s t test. P values 6 0.05 and 0.005 were
considered statistically signiﬁcant and highly signiﬁcant
respectively.3. Results and discussion
OMVs of Shigella have an immunomodulatory role in eliciting
protective immune response in a mouse model [12,14]. The com-
positions of OMVs make signiﬁcant activators of host innate and
acquired immune response pathways. In addition to the potent
immunomodulatory molecule lipopolysaccharides, vesicles con-
tain outer membrane proteins and other important innate
immune-activating proteins. Altogether, vesicle components
appear to act synergistically to modulate the host immune
response in ways that can either stimulate the clearance of the
pathogen, enhance the virulence of the infection, or both. In addi-
tion, the immunogenic properties of OMVs lead to protective
mucosal and systemic bactericidal antibody responses that have
already been studied in our previous research [12,14].
In this study, mice, immunized with either SOMVs or MOMVs,
have elicited signiﬁcant up-regulation of IFN-c, TNF-a, IL-6 and
IL-10 but no IL-1b and IL-4 were observed in vivo (Fig. 1). IFN-c
and TNF-a were observed maximum on day 25th against both
SOMVs and MOMVs followed by a gradual decrease. Whilst IL-6
and IL-10 were seen maximum on the 27th day after fourth
oral immunization and then a sharp decrease. IFN-c (main
pro-inﬂammatory cytokine secreted by Th1 cells) level was signiﬁ-
cantly higher in immunized mice sera. Whilst IL-10 (main
anti-inﬂammatory cytokine secreted by both Th1 and Th2 cells)
too was found in signiﬁcant concentration in mice sera. These data
were found to be statistically signiﬁcant upon comparing
non-vaccinated control to any of the OMVs-type immunized.
IL-6, apart from being a pro-inﬂammatory cytokine, has a role in
anti-inﬂammation and Th2 cell stimulation. It also enhances the
secretion of IL-10 [15–17]. IFN-c and IL-6, both were being
secreted in immunized mice sera establishing a mixed Th1/Th2
response in vivo; although the ratio is shifted more towards Th1
response as observed by signiﬁcantly higher concentration of
IFN-c. These observations explained clearly a balance between
pro-inﬂammatory and anti-inﬂammatory response in mouse,
immunized with OMVs of Shigella. However, MOMVs were seen
to be more powerful in eliciting cytokine response than SOMVs,
with high statistical signiﬁcance.
During ex vivo studies with mouse peritoneal macrophages,
we observed that IL-12 and IL-18 were secreted predominantly
by peritoneal macrophages stimulated with either SOMVs or
MOMVs for overnight. IL-6 and IL-10 were also found in the
macrophage culture supernatant though in lesser amount than
IL-12 and IL-18. IL-12 and IL-18 production were much higher
Fig. 1. Comparison of (A) serum IFN-c, (B) serum TNF-a (C) serum IL-6 and (D) serum IL-10 proﬁle in mouse sera, immunized with either SOMVs or MOMVs. P < 0.05 (*) and
P < 0.005 (**) were considered statistically signiﬁcant and highly signiﬁcant respectively, when compared between ‘‘MOMVs’’ and ‘‘SOMVs’’, on each day. P < 0.05 (+) and
P < 0.005 (++) were considered statistically signiﬁcant and highly signiﬁcant respectively, when each vaccine preparation was compared individually with the control, on each
day.
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ones (Fig. 2) and this difference was statistically signiﬁcant. IL-12
increases Natural Killer (NK) cells and T-cell-IFN-c production,
which shifts T-cell differentiation towards a Th1-type response.
IL-18 is also an IFN-c inducing cytokine that synergize with
IL-12. This result correlates with the data, presented in the previ-
ous paragraph.Fig. 2. (A) IL-12, (B) IL-18, (C) IL-6 and (D) IL-10 secretion by treated and non-treated mo
potent in stimulating the macrophages to make it secrete the cytokines studied here
signiﬁcant respectively, when compared with ‘‘untreated’’.Co-culture of peritoneal macrophage and CD4+ T cell has also
supported this hypothesis. IFN-c was observed chieﬂy in the
co-culture supernatant. IL-4 was also detected, though in minor
amount. IFN-c and IL-4 secretion were signiﬁcantly higher in
OMVs treated culture supernatant when compared with the
untreated group (Fig. 3A and B). Overall, the MOMVs-induced cyto-
kine secretion were higher than SOMVs.use peritoneal macrophages were compared in vitro. MOMVs were seen to be more
. P < 0.05 (*) and P < 0.005 (**) were considered statistically signiﬁcant and highly
Fig. 3. (A) IFN-c and (B) IL-4 secretion were measured in the supernatant of mouse peritoneal macrophage and CD4+ T cells co-culture. MOMVs treated co-culture has been
shown to secrete more cytokines than SOMVs treated and untreated samples. The difference is statistically signiﬁcant. P < 0.05 (*) and P < 0.005 (**) were considered
statistically signiﬁcant and highly signiﬁcant respectively, when compared with ‘‘untreated’’. (C) iNOS mRNA expression was measured by quantitative real time PCR method.
mRNA expression level in mouse peritoneal macrophages were expressed in terms of fold changes. As seen in this graph, MOMVs were more potent in stimulating iNOS
mRNA synthesis in mouse peritoneal macrophages. P < 0.05 (*) and P < 0.005 (**) were considered statistically signiﬁcant and highly signiﬁcant respectively, when compared
with ‘‘untreated’’.
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(NO) which on the other hand, enhances phagocytosis mediated
killing and thus faster clearing of the pathogen. IFN-c plays the
major role in stimulating the inducible isoform iNOS in macro-
phages. This was clearly evident by the RT-PCR of iNOS mRNA in
treated and non-treated macrophages. MOMVs treated macro-
phages showed signiﬁcantly higher value compared to SOMVs
(Fig. 3C).4. Conclusion
OMVs of Shigella seems to modulate Th1/Th2 balance in the sys-
temic circulation, which may have a beneﬁcial role in the disease
activity in immunized individuals being infected with Shigella.
Furthermore, the overall in vivo and in vitro studies had clearly
made an impression of better performance of MOMVs vaccine to
induce protective immunological signals. Hence MOMVs should
be studied further as a novel next-generation vaccine candidate
against shigellosis. This study is beneﬁcial for the easy understand-
ing of the immunomodulation by Shigella OMVs.Conﬂict of interest
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